Countries North America
Cerapedics Expands US Market Access Through Vizient Agreement For PearlMatrix Bone Graft
Agreement expands access to the Cerapedics portfolio of peptide-powered drug-device products for spinal fusion procedures Cerapedics Inc., a global, comme...
April 27, 2026 | News
Medtronic Advances Affera Cardiac Ablation Platform With Strong VT Outcomes And Expanded Clinical Trials
HRS late-breaking data: Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained mo...
April 27, 2026 | News
Sun Pharmaceutical Industries Limited To Acquire Organon & Co. In $11.75 Billion All Cash Deal
Organon stockholders to receive US$ 14.00 per share in cash The deal values Organon at EV of US$ 11.75 billion Combined Business leverages complementar...
April 28, 2026 | News
HanchorBio, Inc. Partners With Bloomberg To Strengthen Data Driven Biopharma Strategy
Expanding HanchorBio's data-enabled approach from molecule design to portfolio and market insight -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stag...
April 27, 2026 | News
Kyowa Kirin Co., Ltd. And Kura Oncology, Inc. Advance Ziftomenib With Japan Phase 2 Trial In NPM1 Mutated AML
Regulatory Filing in Japan Planned Following Clinical Trial Completion – Kyowa Kirin Co., Ltd. (TSE: 4151, “Kyowa Kirin”) and Kura...
April 27, 2026 | News
Akamis Bio Reports Promising Early Efficacy For NG 350A In Rectal Cancer Study
NG-350A combined with chemoradiotherapy demonstrated promising efficacy and a favorable safety profile Composite response rate of 50 percent observed ac...
April 21, 2026 | News
Orthogon Therapeutics Secures 11 Million Dollars To Advance First In Class Oral Therapy For BK Virus In Transplant Patients
Orthogon Therapeutics announced the closing of an $11 million follow-on financing, bringing the total capital raised to $36 million. The financing will ena...
April 21, 2026 | News
EpiBiologics Advances Tissue Selective EGFR Degrader EPI 326 Into First In Human Clinical Study
First-in-human study of EPI-326 will evaluate the company’s lead tissue-selective EGFR degrader in patients with NSCLC and HNSCC with potential to ...
April 21, 2026 | News
Synthetic Design Lab Introduces Logic Gated SYNTHBODY Platform Redefining Precision Protein Therapeutics
SYNTHBODY™ introduces a new class of “smart drugs”: protein therapeutics with built-in, multi-layered logic gates that actively chang...
April 20, 2026 | News
Avantor Expands St Louis Quality Control Capabilities To Accelerate Biopharma Manufacturing
St. Louis site strengthens integrated support for biopharma manufacturing Avantor, Inc, a leading global provider of mission-critical products and ser...
April 20, 2026 | News
DuPont Introduces Slurried AmberChrom XT Resins To Simplify Oligonucleotide And Peptide Purification
New slurried chromatography resins eliminate resin hydration step to help accelerate downstream purification of oligonucleotides and peptides DuPont annou...
April 20, 2026 | News
Labcorp Launches First FDA Cleared Rapid Fentanyl Urine Test Made In The United States
First FDA-cleared rapid fentanyl test of its kind made in the United States designed to help emergency department and hospital teams ...
April 20, 2026 | News
Thermo Fisher Introduces PowerFlex Thermal Cycler To Simplify Complex PCR Workflows
A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible res...
April 17, 2026 | News
Protaryx Medical Secures FDA 510(k) Clearance For Transseptal Puncture Device
Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, announced that ...
April 15, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
